Real-time enrollment status for this low-grade glioma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT05566795 |
| Recruiting Status | Recruiting |
| Condition | Low-Grade Glioma |
| Phase | Clinical Trial |
| Target Enrollment | 400 participants |
| Active Locations | 35 sites in the US |
| Sponsor | Day One Biopharmaceuticals, Inc. |
| Last Updated on CT.gov | November 6, 2025 (Nov 6, 2025) |
As of March 2, 2026: Clinical trial NCT05566795 is currently recruiting participants. This clinical trial study for low-grade glioma is actively seeking new participants at 35 locations across the United States. The study is sponsored by Day One Biopharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05566795 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 35 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05566795 was last updated Nov 6, 2025 (November 6, 2025). HelloStudys verifies this status automatically.